Why MusclePharm (MSLP) Stock Is Gaining On Monday
at The Street - Mon May 05, 10:01AM CDT
MusclePharm (MSLP) stock is higher today after reporting increases in net sales and net income for the 2014 first quarter.
MusclePharm Reports 2014 First Quarter Financial Results
Marketwire - Mon May 05, 7:03AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company today announced financial results for the first quarter ended March 31, 2014.
MusclePharm to Report 2014 First Quarter Financial Results
Marketwire - Tue Apr 29, 8:04AM CDT
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the first quarter ended March 31, 2014 on Monday, May 5, 2014, following market close.
Clinical Study of MusclePharm's Award Winning Pre-Workout Supplement Assault(TM) Published in Nutrition Research Journal
Marketwire - Mon Apr 28, 7:02AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that Nutrition Research, an international publication for nutrition to advance food and life science research, published the results of a double-blind placebo-controlled clinical study demonstrating safety and efficacy of MusclePharm's pre-workout supplement Assault(TM).
MusclePharm Announces Key Executive Appointments
Marketwire - Mon Apr 14, 7:01AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced the appointment of Donald W. Prosser as Chief Financial Officer and the promotion of Richard Estalella to President, in addition to his role as Chief Operating Officer.
MusclePharm's FitMiss Brand Signs Jen Selter to Multi-Year Endorsement Deal
Marketwire - Wed Apr 09, 7:03AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced it has signed a multi-year endorsement deal with fitness model and motivator Jen Selter. The agreement adds to the company's presence in the rapidly-expanding world of women's fitness.
MusclePharm Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Mon Mar 31, 7:03AM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced financial results for the fourth quarter and full year ended Dec. 31, 2013.
MusclePharm Schedules Fiscal 2013 Fourth Quarter and Full Year Financial Results Press Release and Conference Call for March 31, 2014
Marketwire - Mon Mar 24, 3:30PM CDT
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, will report its financial results for the fourth quarter and full year ended Dec. 31, 2013 on Monday, March 31, 2014, prior to market open. The company will also conduct a conference call at 11 a.m. Eastern Time/8 a.m. Pacific Time on the same day to discuss the results.
USA Wrestling Names MusclePharm as Its Exclusive Official Nutritional Supplement Provider
Marketwire - Thu Mar 06, 7:15AM CST
USA Wrestling, the national governing body for wrestling in the United States, has signed MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, as its exclusive official nutritional supplement provider.
The Arnold Schwarzenegger Blueprint by MusclePharm Debuts at BodyBuilding.com
Marketwire - Thu Feb 27, 7:04AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced the launch of The Arnold Schwarzenegger(TM) Blueprint at BodyBuilding.com leading up to the annual Arnold Sports Festival in Columbus, Ohio from Feb. 27 - March 2, 2014.
MusclePharm Sports Science Institute Hosts RockTape Fascial Movement Taping Workshop
Marketwire - Wed Feb 26, 12:30PM CST
MusclePharm Corporation, a leading international, award-winning sports nutrition company, recently hosted a RockTape Fascial Movement Taping workshop to provide training and certification for kinesiology taping techniques. Fascial Movement Taping is a technique based on muscles acting as a chain to create efficient, fluid patterns.
MusclePharm CEO Issues Update Letter to Shareholders
Marketwire - Wed Jan 29, 8:01AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading, award-winning sports nutrition company, today issued the following letter to shareholders from its Chairman and CEO, Brad Pyatt:
MusclePharm Corporation acquires BioZone Pharmaceuticals' assets
M2 - Tue Jan 07, 5:52AM CST
Sports nutrition company MusclePharm Corporation (OTCQB:MSLP) revealed on Monday the completion of the acquisition of essentially all assets of BioZone Pharmaceuticals Inc (OTCBB: BZNE) and its subsidiaries, for 1.2m shares of MusclePharm stock.
MusclePharm Completes Acquisition of Substantially All Assets of BioZone Pharmaceuticals
Marketwire - Mon Jan 06, 7:31AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has completed the acquisition of essentially all assets of BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) and its subsidiaries, for 1.2 million shares of MusclePharm stock.
MusclePharm Names PondelWilkinson as Investor Relations Counsel
Marketwire - Tue Dec 31, 7:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has retained PondelWilkinson Inc. as investor relations counsel.
BioZone Pharmaceuticals, Inc. Completes Balance Sheet Enhancement
Marketwire - Tue Dec 24, 7:00AM CST
BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) announced today that it has completed an enhancement of its balance sheet by eliminating remaining outstanding convertible notes. In the recent transaction, holders of convertible notes with approximately $2.5 million of principal and accrued interest exchanged their securities for shares of common stock. OPKO Health Inc. (NYSE: OPK), a principal shareholder of BioZone Pharmaceuticals and one of the note holders that converted its notes, expressed the view through its Chairman and CEO, Dr. Phillip Frost, that it is optimistic that the planned acquisition of Cocrystal Discovery will enhance shareholder value and enhance BioZone's future prospects as a high growth biotech company.
MusclePharm Announces New $5 Million Share Repurchase Program
Marketwire - Tue Dec 10, 9:01AM CST
MusclePharm Corporation (OTCQB: MSLP) (the "Company"
BioZone Pharmaceuticals, Inc. Enhances Balance Sheet
Marketwire - Mon Dec 02, 7:46AM CST
BioZone Pharmaceuticals, Inc. (OTCQB: BZNE) announced today that it has enhanced its balance sheet significantly by eliminating outstanding convertible preferred stock. In the recent transaction, holders of convertible preferred stock, with a stated value of $3.5 million and a 10% dividend, exchanged their securities for shares of common stock. Key holders expressed the view that the recently announced merger with Cocrystal Discovery, Inc. is a significant positive development for the Company.
Ultimate Fighting Championship® (UFC), MusclePharm® Renew Partnership
PR Newswire - Mon Dec 02, 6:30AM CST
The Ultimate Fighting Championship® announced a multi-year renewal with MusclePharm® Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company. In addition to branding in the hallowed Octagon®, MusclePharm will be featured in a variety of UFC programming elements ranging from national television broadcasts to Pay-Per-Views and across UFC's digital platforms. The sponsorship also involves special events and the use of official marks and logos for consumer retail promotions including a special Octagon-shaped Fight Pack.
MusclePharm Sports Science Center Hosts Top Researchers, Coaches, Practitioners, Students for National Strength and Conditioning Association Event
PR Newswire - Tue Nov 26, 6:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, recently hosted the National Strength and Conditioning Association (NSCA) Colorado State Clinic which featured leading U.S. researchers and speakers including Dr. Jordan Moon, Colorado State Director, NSCA and Dr. Eric Serrano, Chief Medical Officer, of MusclePharm and Director of the company's Research Institute.